Trial Profile
Combination Therapy for the Treatment of Obstructive Sleep Apnea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Mar 2017
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Sleep apnoea syndrome
- Focus Therapeutic Use
- 21 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 29 Jan 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Jul 2014 to 1 Dec 2014.
- 22 May 2013 Preliminary results for 5 patients presented at the 109th International Conference of the American Thoracic Society.